1. Japan Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Create Medic Co., Ltd.

Create Medic Co., Ltd.

TTSE:5187
1,110.00
JPY
-7.00
(-0.63%)
8.82BMarket Cap
Nov 02Next Earn
Create Medic Co., Ltd.
TSE:5187
(Tokyo Stock Exchange)

Recent

price

1,110.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
JPY
945.98
969.7
970.38
1,027.46
1,033.64
1,003.6
1,059.49
1,115.72
1,159.04
1,164.1
1,169.04
1,286.28
1,354.87
1,382.67
1,478.44
1,607.47
- -
Revenue per Share
69.41
60.66
53.27
55.49
50.96
34.64
54.73
50.23
72.2
77.83
71.19
72.61
53
16.92
95.41
84.25
- -
Basic EPS, GAAP
43.32
49.84
-44.5
16.98
120.72
-6.74
99.65
23.47
37.95
67.99
90.56
69.22
12.75
27.13
201.24
7.99
- -
Free Cash Flow per Basic Share
33.08
32.94
33.03
33.96
35.09
35.01
35.15
34.97
35
37.9
37.17
36.93
36.94
36.88
39.52
37.15
- -
Dividend per Share
1,118.52
1,144.47
1,192.47
1,288.15
1,341.24
1,366.83
1,352.97
1,381.4
1,383.31
1,414.36
1,454.41
1,563.55
1,618.1
1,641.59
1,833.67
1,947.78
2,056.75
Book Value per Share
1,102.07
1,127.46
1,174.14
1,267.05
1,318.47
1,345.37
1,330.35
1,357.65
1,360.27
1,389.21
1,406.41
1,488.05
1,548.11
1,579.45
1,771.73
1,897.84
2,010.85
Tangible Book Value per Share
10
10
10
10
10
10
9
9
9
9
9
9
9
9
9
8
8
Basic Weighted Avg Shares
9,097
9,325
9,332
9,881
9,940
9,651
10,003
10,394
10,797
10,844
10,830
11,699
12,327
12,585
13,030
13,618
- -
Sales/Revenue/Turnover
13.53
10.74
7.93
8.35
7.89
6.72
7.54
8.22
9.2
9.99
9.09
7.41
6.01
6.38
5.31
7.38
- -
Operating Margin (%)
227
239
274
306
349
320
332
349
349
390
406
462
605
588
637
570
- -
Depreciation Expense
668
583
512
534
490
333
517
468
673
725
660
660
482
154
841
714
- -
Net Income, GAAP
40.12
44.56
44.23
40.37
40.78
46.2
36.01
39.18
31.39
34.18
33
31.61
44.13
82.96
22.63
32.71
- -
Effective Tax Rate (%)
7.34
6.26
5.49
5.4
4.93
3.45
5.17
4.5
6.23
6.69
6.09
5.65
3.91
1.22
6.45
5.24
- -
Profit Margin (%)
7,103
6,565
7,173
7,548
8,414
7,990
8,139
8,073
8,122
8,478
8,140
9,002
9,312
9,756
10,835
12,199
12,041
Working Capital
97
43
1,003
944
603
562
691
275
259
92
- -
- -
- -
- -
- -
750
750
LT Debt
10,757
11,006
11,468
12,362
12,897
13,143
12,604
12,868
12,886
13,175
13,228
14,220
14,724
14,944
15,751
16,332
16,489
Total Equity
6.12
4.47
3.13
3.44
3.13
2.34
3.27
3.56
4.72
4.95
4.61
4.04
2.69
0.87
3.3
4
- -
Return on Invested Capital (%)
5.72
4.83
4
3.85
3.38
2.29
3.57
3.27
4.72
5.12
4.67
4.56
3.18
1
5.26
4.28
- -
Return on Capital (%)
6.26
5.36
4.56
4.48
3.88
2.56
4.01
3.67
5.22
5.56
5
4.81
3.33
1.04
5.48
4.45
- -
Return on Common Equity (%)

Capital Structure

JPY

•

in mil. unless spec.
Jun'24
Mar'26
Jun'26
ST Debt
800
- -
- -
LT Borrowings
- -
- -
750
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
9
8
8
Market Capitalization
8,317
9,416
8,819

Working Capital

JPY

•

in mil. unless spec.
Jun'24
Mar'26
Jun'26
Total Current Assets
13,794
- -
13,641
Cash, Cash Equivalents & STI
6,139
- -
5,637
Accounts Receivable, Net
1,842
- -
1,915
Inventories
4,085
- -
4,348
Total Current Liabilities
2,826
- -
1,599
Payables & Accruals
- -
- -
- -
ST Debt
800
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
2.24%
4.33%
3.69%
Free Cash Flow
-92.66%
105.65%
-96.18%
Net Income, GAAP
42.41%
67.19%
-15.12%
Sales/Revenue/Turnover
3.53%
4.71%
4.51%
Total Cash Common Dividend
-0.58%
-1.68%
-9.64%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,976
3,324
- -
- -
13,030
2025
- -
- -
- -
- -
13,618
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
6.51
54.84
- -
- -
95.41
2025
- -
- -
- -
- -
84.25
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
39.52
2025
- -
- -
- -
- -
37.15
2026
- -
- -
- -
- -
- -
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Create Medic Co., Ltd. (5187.T) manufactures and sells silicone-based medical devices, primarily catheters and tubes for urological, gastroenterological, surgical, and respiratory applications. Founded in August 1974 and headquartered in Yokohama, Kanagawa, Japan, the company produces an extensive range of products including all-silicone Foley balloon catheters, hematuria balloon catheters, Tiemann balloon catheters, self-catheterization sets, nephrostomy kits, suprapubic balloon catheters, ileus tubes, stomach tubes, percutaneous endoscopic gastrostomy (PEG) kits with loop fixtures, CLINY introducer PEG kits, balloon button sets, PTC drainage tubes, PTCD kits, cholangio-entero tubes, endotracheal tubes, tracheostomy tubes, and micro catheters; it also offers OEM services and brands such as Cliny across these categories. Operations span Japan and international markets through subsidiaries like Dalian Create Medical Products Co., Ltd. in China, Vietnam Create Medic Co., Ltd., Kyushu Create Medic Co., Ltd. in Japan, and Create Medic International Trading (Dalian) Co., Ltd., serving hospitals, clinics, and healthcare providers globally with a workforce of 1,002 employees and net sales of 13,030 million yen for the year ended December 2024. In recent developments, the company relocated its head office to Kohoku-ku, Yokohama in November 2024, renamed its R&D Center as the Tonomachi Innovation Office and R&D Center in September 2024, and continues assessments for MDR compliance on key products like ileus tubes and PTCD kits while reporting financial results, including third-quarter 2025 summaries; capital stands at 1,461 million yen as of year-end 2024 with leadership under President Osamu Imazawa and Chairman Masahiro Sato.